Johanniter-Krankenhaus im Fläming Treuenbrietzen GmbH

Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis (2023) Kreuter M, Bonella F, Blank N, Riemekasten G, Mueller-Ladner U, Henes J, Siegert E, et al. Journal article Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry (2022) Blank N, Schmalzing M, Moinzadeh P, Oberste M, Siegert E, Mueller-Ladner U, Riemekasten G, et al. Journal article DOES ANTI-ACID TREATMENT INFLUENCE DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE (SSC-ILD)? DATA FROM THE GERMAN SSC-NETWORK (2020) Kreuter M, Bonella F, Riemekasten G, Mueller-Ladner U, Henes J, Siegert E, Guenther C, et al. Conference contribution ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem (2020) Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, Buhl R, et al. Journal article, Review article Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry (2019) Kraft M, Knop MP, Renaudin JM, Scherer Hofmeier K, Pfoehler C, Bilo MB, Lang R, et al. Journal article Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Significance of pulmonary involvement in systemic sclerosis (SSc)- data from the German SSc-network (2018) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution EVALUATION OF FREQUENCY AND TYPE OF PHYSICAL THERAPY IN MORE THAN 3400 PATIENTS WITH SYSTEMIC SCLEROSIS (2017) Belz D, Moinzadeh P, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution